6-158158343-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032861.4(SERAC1):āc.21C>Gā(p.Cys7Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000533 in 1,613,298 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_032861.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152122Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000330 AC: 83AN: 251240Hom.: 1 AF XY: 0.000493 AC XY: 67AN XY: 135780
GnomAD4 exome AF: 0.000558 AC: 816AN: 1461058Hom.: 1 Cov.: 29 AF XY: 0.000618 AC XY: 449AN XY: 726880
GnomAD4 genome AF: 0.000289 AC: 44AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.000390 AC XY: 29AN XY: 74442
ClinVar
Submissions by phenotype
3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome Uncertain:4
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
- -
This sequence change replaces cysteine, which is neutral and slightly polar, with tryptophan, which is neutral and slightly polar, at codon 7 of the SERAC1 protein (p.Cys7Trp). This variant is present in population databases (rs139301835, gnomAD 0.1%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with SERAC1-related conditions. ClinVar contains an entry for this variant (Variation ID: 215139). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
not provided Pathogenic:1
p.Cys7Trp (TGC>TGG): c.21 C>G in exon 2 of the SERAC1 gene (NM_032861.3) A C7W variant that is likely pathogenic was identified in the SERAC1 gene. It has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The C7W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is highly conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, this variant is a strong candidate for a pathogenic mutation, however the possibility that it is a benign variant cannot be excluded.The variant is found in MITONUC-MITOP panel(s). -
Inborn genetic diseases Uncertain:1
The c.21C>G (p.C7W) alteration is located in exon 2 (coding exon 1) of the SERAC1 gene. This alteration results from a C to G substitution at nucleotide position 21, causing the cysteine (C) at amino acid position 7 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at